Clinical Trials Logo
  1. Home
  2. Anxiety Disorder
  3. NCT00229281
  4. Details
NCT00229281 Clinical Trial

Short Term Group Therapy for Anxiety Disorder

Anxiety Disorder Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00229281
Other study ID # SHEBA-05-3680-JZ-CTIL
Secondary ID
Status Completed
Phase N/A
First received September 28, 2005
Last updated December 18, 2007
Start date February 2004

Study information
Verified date December 2007
Source Sheba Medical Center
Contact n/a
Is FDA regulated No
Health authority Israel: Israeli Health Ministry Pharmaceutical Administration
Study type Interventional

Clinical Trial Summary

Assessing Anxiety in patient suffering from anxiety disorders (NOT OCD or PTSD)before and after group therapy

Recruitment information / eligibility
Status Completed
Enrollment 30
Est. completion date
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Anxiety disorder (other than OCD or PTSD)

- Eligibility to participate in group therapy

Exclusion Criteria:

- OCD

- PTSD

- Suicidal thoughts

- Psychotic state

- Severe hostile personality disorder

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Intervention

Behavioral:
• Group therapy

Locations
Country Name City State
Israel Chaim Sheba Medical Center Ramat-Gan

Sponsors (1)
Lead Sponsor Collaborator
Sheba Medical Center

Country where clinical trial is conducted

Israel, 

See also
  Status Clinical Trial Phase
Recruiting NCT06038721 - Unified Protocol: Community Connections N/A
Not yet recruiting NCT03224845 - Courageous Parents, Courageous Children N/A
Completed NCT02096783 - Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer N/A
Completed NCT02145429 - Preventing Depression in Late Life: A Model for Low and Middle Income Countries N/A
Completed NCT00794456 - Association of Passiflora Incarnata L; Crataegus Oxyacantha L and Salix Alba L. on Mild and Moderate Anxiety Phase 3
Terminated NCT00896467 - Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy N/A
Completed NCT00252343 - Efficacy and Safety of SR58611A in Patients With a Generalized Anxiety Disorder Phase 3
Not yet recruiting NCT05867823 - OcupApp: Occupational Self-analysis Intervention Through an Mobile Application N/A
Recruiting NCT04562324 - Efficacy of Electroencephalography (EEG) Neurofeedback (NF) for the Treatment of Anxiety Disorder N/A
Recruiting NCT05989451 - Adaptation of Individual Dialectical Behavior Therapy Intervention for Transdiagnostic Treatment of Emotional Disorders N/A
Not yet recruiting NCT05488418 - Clinical Study of Biomarkers of Stress Resilience: Role of ELK1 and GPR56 N/A
Not yet recruiting NCT03608449 - Doing More With Less": Optimizing Psychotherapeutic Services in the Mental Health System N/A
Completed NCT03400397 - An Effectiveness Study of the Cool Kids Programme N/A
Completed NCT00025844 - Fear Conditioning Using Computer-Generated Virtual Reality N/A
Completed NCT02579928 - Ketamine Infusion for Adolescent Depression and Anxiety Phase 4
Completed NCT02270073 - The Process Outcome Mindfulness Effects in Trainees (PrOMET)-Study N/A
Terminated NCT03764644 - Web-based Attention Bias Modification Treatment for Childhood Anxiety Disorders N/A
Completed NCT01425619 - The Effect of Medical Clowns and Topical Anesthetic Cream on Pain and Anxiety in Children Undergoing Allergy Skin Tests N/A
Completed NCT01721824 - The Effect of IPS-MA- A Modified Early Supported Employment Intervention for Individuals With Mood or Anxiety Disorders N/A
Completed NCT01764789 - Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer N/A